CureVac N.V. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
CVAC Nasdaq 2836 www.curevac.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for CureVac N.V.

CureVac N.V.'s (NASDAQ:CVAC) largest shareholders are individual investors with 38% ownership, private equity firms own 31% - Mar 10th, 2025 11:09 am
Is CureVac N.V. (CVAC) the Best Get Rich Fast Stock to Buy Now? - Feb 20th, 2025 3:32 pm
CureVac Earns Repeat Recognition by LexisNexis(R) as One of the World’s Top Innovators - Feb 18th, 2025 12:15 pm
Discovering Giftify And 2 Other US Penny Stocks With Promising Potential - Feb 10th, 2025 5:11 pm
Companies Like CureVac (NASDAQ:CVAC) Are In A Position To Invest In Growth - Jan 23rd, 2025 1:47 pm
Moderna stock forfeits gains as first US bird flu death puts vaccine development in focus - Jan 8th, 2025 9:03 pm
Vaccine Stocks Jump After CDC Reports First US Bird-Flu Death - Jan 8th, 2025 11:52 am
Moderna Stock Jumps Amid Bird Flu Vaccine Hope After First U.S. Death - Jan 7th, 2025 5:12 pm
Discover 3 US Penny Stocks With Market Caps Over $200M - Dec 27th, 2024 1:04 pm
Cerus And 2 Other US Penny Stocks To Watch - Nov 28th, 2024 1:07 pm
Loss-Making CureVac N.V. (NASDAQ:CVAC) Set To Breakeven - Nov 26th, 2024 5:25 pm
Is the Options Market Predicting a Spike in CureVac (CVAC) Stock? - Nov 20th, 2024 4:18 pm
Is CureVac N.V. (CVAC) the Best German Stock to Buy Now? - Nov 19th, 2024 11:31 pm
Where are they now? 4 biotechs that soared then crashed during the pandemic - Nov 15th, 2024 7:08 am
CureVac NV (CVAC) Q3 2024 Earnings Call Highlights: Strong Financial Performance and Strategic ... - Nov 13th, 2024 7:13 am
CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update - Nov 12th, 2024 12:20 pm
CureVac to Report Third Quarter and First Nine Months 2024 Financial Results and Business Update on November 12, 2024 - Nov 7th, 2024 12:30 pm
CureVac Strengthens Leadership Team with Appointment of Seasoned Industry Executive Axel Sven Malkomes as Chief Financial Officer - Nov 4th, 2024 12:20 pm
CureVac to Present at the 12th International mRNA Health Conference - Nov 4th, 2024 12:15 pm
US Penny Stocks To Watch In October 2024 - Oct 30th, 2024 5:07 pm